RA

Rajni Aashish Nair

Active Director Designated Partner DIN 11533538
DIN 11533538 First appointment Feb 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Rajni Aashish Nair

Data last updated:

Rajni Aashish Nair is a Designated Partner at Asepticore Pharmaceuticals Llp (since 2026). The company operates in Pharma.

DIN 11533538
Primary Designation Designated Partner
Industry Pharma
First Appointment 09 Feb 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner09 Feb 20262026Active

Board colleagues of Rajni Aashish Nair

NameDINCompanyDesignation
Pandya Gautami11533540Asepticore Pharmaceuticals LlpDesignated Partner
Sonalben Mistry11533539Asepticore Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Asepticore Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Rajni Aashish Nair

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajni Aashish Nair

Rajni Aashish Nair currently holds 1 directorship: Asepticore Pharmaceuticals Llp (Designated Partner, since 09 Feb 2026).

Rajni Aashish Nair was first appointed on 09 Feb 2026 as Designated Partner at Asepticore Pharmaceuticals Llp.

The current boards of Rajni Aashish Nair's companies include Pandya Gautami (Asepticore Pharmaceuticals Llp), Sonalben Mistry (Asepticore Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available